Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - PubMed (original) (raw)
Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Kegan J Moneghetti et al. Sci Rep. 2018.
Abstract
Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/CFS) is a heterogeneous syndrome in which patients often experience severe fatigue and malaise following exertion. Immune and cardiovascular dysfunction have been postulated to play a role in the pathophysiology. We therefore, examined whether cytokine profiling or cardiovascular testing following exercise would differentiate patients with ME/CFS. Twenty-four ME/CFS patients were matched to 24 sedentary controls and underwent cardiovascular and circulating immune profiling. Cardiovascular analysis included echocardiography, cardiopulmonary exercise and endothelial function testing. Cytokine and growth factor profiles were analyzed using a 51-plex Luminex bead kit at baseline and 18 hours following exercise. Cardiac structure and exercise capacity were similar between groups. Sparse partial least square discriminant analyses of cytokine profiles 18 hours post exercise offered the most reliable discrimination between ME/CFS and controls (κ = 0.62(0.34,0.84)). The most discriminatory cytokines post exercise were CD40L, platelet activator inhibitor, interleukin 1-β, interferon-α and CXCL1. In conclusion, cytokine profiling following exercise may help differentiate patients with ME/CFS from sedentary controls.
Conflict of interest statement
The authors declare no competing interests.
Figures
Figure 1
Clinical demographics of Controls and ME/CFS. There was a significant difference in MFI-20 between controls and participants with ME/CFS (A). Groups were similar with regard to maximal oxygen consumption (peak VO2) (B), however, MFI-20 did not correlate to peak VO2 (C). There was a reduction in absolute heart rate recovery slope in patients with ME/CFS when compared to controls (D).
Figure 2
Network of the change in cytokines with exercise. Vertex colors are dark blue for strongly negative average delta to dark red for strongly positive average delta. Degree of centrality of cytokines is represented by the diameter of its vertex. The diameter of a cytokine’s vertex is proportional to its quantity of direct direct connections (blue lines) with other cytokines. In (A) Controls: IL-5, TNF-alpha and IL-2 are richly connected while in (B) ME/CFS: CXCL10, VEGF and IL-15 are richly interconnected. IL-4 appeared to play a similar role in both networks.
Figure 3
Partial Least Square discriminant analysis to identify factors associated with ME/CFS case status. Kappa (κ) is coefficient of chance-adjusted agreement, here between observed case status and predicted case status from sPLSDA. Cross-validated discriminatory cytokines are those above the horizontal dashed red line. At Baseline (A) 18 hours post exercise (B) and delta change between A and B (C) Summary of sPLSDA with κ coefficients (D).
Similar articles
- Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.
Bouquet J, Li T, Gardy JL, Kang X, Stevens S, Stevens J, VanNess M, Snell C, Potts J, Miller RR, Morshed M, McCabe M, Parker S, Uyaguari M, Tang P, Steiner T, Chan WS, De Souza AM, Mattman A, Patrick DM, Chiu CY. Bouquet J, et al. PLoS One. 2019 Mar 21;14(3):e0212193. doi: 10.1371/journal.pone.0212193. eCollection 2019. PLoS One. 2019. PMID: 30897114 Free PMC article. - Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Shukla SK, Cook D, Meyer J, Vernon SD, Le T, Clevidence D, Robertson CE, Schrodi SJ, Yale S, Frank DN. Shukla SK, et al. PLoS One. 2015 Dec 18;10(12):e0145453. doi: 10.1371/journal.pone.0145453. eCollection 2015. PLoS One. 2015. PMID: 26683192 Free PMC article. - Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.
Clark LV, Buckland M, Murphy G, Taylor N, Vleck V, Mein C, Wozniak E, Smuk M, White PD. Clark LV, et al. Clin Exp Immunol. 2017 Dec;190(3):360-371. doi: 10.1111/cei.13023. Epub 2017 Oct 11. Clin Exp Immunol. 2017. PMID: 28779554 Free PMC article. Clinical Trial. - Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review.
Nijs J, Nees A, Paul L, De Kooning M, Ickmans K, Meeus M, Van Oosterwijck J. Nijs J, et al. Exerc Immunol Rev. 2014;20:94-116. Exerc Immunol Rev. 2014. PMID: 24974723 Review. - Chronic fatigue syndrome and circulating cytokines: A systematic review.
Blundell S, Ray KK, Buckland M, White PD. Blundell S, et al. Brain Behav Immun. 2015 Nov;50:186-195. doi: 10.1016/j.bbi.2015.07.004. Epub 2015 Jul 3. Brain Behav Immun. 2015. PMID: 26148446 Review.
Cited by
- Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.
Bouquet J, Li T, Gardy JL, Kang X, Stevens S, Stevens J, VanNess M, Snell C, Potts J, Miller RR, Morshed M, McCabe M, Parker S, Uyaguari M, Tang P, Steiner T, Chan WS, De Souza AM, Mattman A, Patrick DM, Chiu CY. Bouquet J, et al. PLoS One. 2019 Mar 21;14(3):e0212193. doi: 10.1371/journal.pone.0212193. eCollection 2019. PLoS One. 2019. PMID: 30897114 Free PMC article. - Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention Study.
Sørland K, Sandvik MK, Rekeland IG, Ribu L, Småstuen MC, Mella O, Fluge Ø. Sørland K, et al. Front Med (Lausanne). 2021 Mar 22;8:642710. doi: 10.3389/fmed.2021.642710. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33829023 Free PMC article. - Placenta-Expanded Stromal Cell Therapy in a Rodent Model of Simulated Weightlessness.
Rubinstein L, Paul AM, Houseman C, Abegaz M, Tabares Ruiz S, O'Neil N, Kunis G, Ofir R, Cohen J, Ronca AE, Globus RK, Tahimic CGT. Rubinstein L, et al. Cells. 2021 Apr 19;10(4):940. doi: 10.3390/cells10040940. Cells. 2021. PMID: 33921854 Free PMC article. - A review of cytokine-based pathophysiology of Long COVID symptoms.
Low RN, Low RJ, Akrami A. Low RN, et al. Front Med (Lausanne). 2023 Mar 31;10:1011936. doi: 10.3389/fmed.2023.1011936. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37064029 Free PMC article. - Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
Gómez-Mora E, Carrillo J, Urrea V, Rigau J, Alegre J, Cabrera C, Oltra E, Castro-Marrero J, Blanco J. Gómez-Mora E, et al. Front Immunol. 2020 Nov 17;11:582330. doi: 10.3389/fimmu.2020.582330. eCollection 2020. Front Immunol. 2020. PMID: 33329554 Free PMC article.
References
- Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue, S., Board on the Health of Select, P. & Institute of, M. In Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illnesswww.nap.edu/download/19012 (2015) - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical